Immunophenotypic Analysis in Early Müllerian Serous Carcinogenesis

Area of Science:

• Gynecologic Oncology
• Pathology
• Molecular Biology

Background:

• Limited data exists on the immunophenotypes of early-stage serous carcinomas in the female genital tract.
• Understanding these early changes is crucial for accurate diagnosis and treatment strategies.

Purpose of the Study:

• To analyze the expression of p53, p16(Ink4a), estrogen receptor (ER), progesterone receptor (PR), ERBB2, WT1, and Ki-67 proteins.
• To investigate these markers in endometrial intraepithelial carcinoma, serous tubal intraepithelial lesion (STIC), and the p53 signature precursor lesion.

Main Methods:

• Immunohistochemical analysis of protein expression.
• Evaluation of endometrial intraepithelial carcinoma (n=29), STIC (n=10), serous tubal intraepithelial lesion (n=4), and p53 signature (n=11) cases.
• Comparative analysis of marker expression across different precursor and early carcinoma stages.

Main Results:

• p53 overexpression was noted in endometrial intraepithelial carcinoma (80%) and STIC (90%).
• p16(Ink4a) was positive in all endometrial intraepithelial carcinoma and STIC cases, but negative in the p53 signature.
• ER and PR showed variable positivity, while ERBB2 was negative in STICs.

Conclusions:

• p16(Ink4a) appears to be involved in early Müllerian serous carcinogenesis, emerging after the p53 signature stage.
• p16(Ink4a) immunohistochemistry can serve as a diagnostic aid for p53-null lesions.
• Further research into these markers may refine early detection and classification of gynecologic serous cancers.